Clinical Development

Pipeline /
Clinical Trials

Clinical Development

Pipeline /
Clinical Trials

Advancing our proprietary technology platform

FOCUSED PIPELINE WITH STRONG GROWTH POTENTIAL AND THE POWER TO IMPROVE PATIENTS’ LIVES

We are driving our proprietary technology platform forward, with a focused pipeline that holds immense growth potential and the capability to enhance the lives of patients. Our innovative technology leverages the regenerative properties of a patient’s own skin to address various skin-related conditions. With robust clinical evidence and peer-reviewed publications supporting our approach, our late-stage pipeline concentrates on utilizing the RECELL® System to prepare and administer Spray-On Skin™ Cells for treating injuries and skin defects.

WOUND HEALING
thermal burn wounds | full-thickness skin defects

REPIGMENTATION
vitiligo patients

U.S.
International Distributors
U.S.
International Distributors
US

Current clinical trials

Repigmentation of stable vitiligo lesions

Click here for more information about eligibilty and enrollment in AVITA Medical’s Vitiligo Clinical Study.

The TONE Study: A Prospective Post-Market Clinical Study Investigating Reigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Study: NCT05971381 on clinicaltrials.gov

RECELL provides point-of-care regenerative therapy for thermal burn wounds and full-thickness skin defects.